Ashley Hall Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

Ashley Hall is Chief Development Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 22,500 shares of ESPR, which is worth approximately $57,825. The most recent transaction as insider was on Jan 28, 2021, when has been sold 7,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K
0% 3M change
0% 12M change
Total Value Held $57,825

Ashley Hall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 28 2021
BUY
Grant, award, or other acquisition
-
7,000 Added 23.73%
22,500 Common Stock

Also insider at

RPHM
Reneo Pharmaceuticals, Inc. Healthcare
Chief Development Officer
GPCR
Structure Therapeutics Inc.
Chief Development Officer
AH

Ashley Hall

Chief Development Officer
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR